INS and obesity disorder: Furthermore, their activity is central to fuelling chronic inflammation, contributing to metabolic dysfunction seen in obesity, and promoting the development of insulin resistance by impairing insulin signalling pathways and damaging pancreatic β-cells, making them significant targets for future therapeutic strategies (Table 1).